Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

James Suen

Concepts (317)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Arteriovenous Malformations
9
2018
76
1.520
 Why?
Head and Neck Neoplasms
14
2012
288
1.280
 Why?
Carcinoma, Squamous Cell
12
2011
326
0.870
 Why?
Neck
7
2018
100
0.700
 Why?
Vascular Malformations
3
2010
102
0.650
 Why?
Head
5
2018
72
0.620
 Why?
Patients
1
2018
49
0.570
 Why?
Terminal Care
1
2018
46
0.570
 Why?
Hemangioma
3
2018
83
0.550
 Why?
Attitude to Health
1
2018
190
0.530
 Why?
Flow Cytometry
7
2024
472
0.530
 Why?
Laryngectomy
3
2013
27
0.530
 Why?
Laryngeal Neoplasms
2
2007
43
0.500
 Why?
Quality of Life
3
2012
850
0.460
 Why?
Carcinoma, Merkel Cell
4
2016
40
0.460
 Why?
Laser Therapy
3
2011
83
0.450
 Why?
Laryngeal Diseases
1
2013
12
0.410
 Why?
Nuclear Proteins
6
2015
235
0.410
 Why?
Herpes Simplex
1
2013
23
0.410
 Why?
Parotid Diseases
1
2012
3
0.400
 Why?
Neuromuscular Agents
1
2012
8
0.400
 Why?
Botulinum Toxins, Type A
1
2012
14
0.400
 Why?
Leukoplakia, Oral
1
2011
6
0.380
 Why?
Aminolevulinic Acid
1
2011
8
0.380
 Why?
Lasers, Dye
1
2011
10
0.380
 Why?
Eating
1
2012
158
0.380
 Why?
Photosensitizing Agents
1
2011
19
0.370
 Why?
Photochemotherapy
1
2011
33
0.370
 Why?
Survivors
1
2012
126
0.370
 Why?
Female
30
2024
27053
0.360
 Why?
Humans
49
2024
50419
0.360
 Why?
Middle Aged
21
2024
12579
0.350
 Why?
Male
30
2024
25866
0.340
 Why?
Photoacoustic Techniques
2
2024
71
0.340
 Why?
Cheek
1
2010
9
0.340
 Why?
Lip
1
2010
10
0.330
 Why?
Neoplastic Cells, Circulating
4
2019
74
0.330
 Why?
Facial Neoplasms
1
2010
22
0.330
 Why?
Pain
1
2012
386
0.330
 Why?
Adult
21
2024
13561
0.320
 Why?
Receptors, Progesterone
1
2009
64
0.320
 Why?
Aged
16
2018
9738
0.320
 Why?
Postoperative Complications
3
2012
1030
0.310
 Why?
Lymphatic Vessels
1
2009
53
0.310
 Why?
Skin Neoplasms
4
2016
492
0.300
 Why?
Neoplasms
1
2018
1248
0.290
 Why?
Antineoplastic Combined Chemotherapy Protocols
2
2004
997
0.290
 Why?
Surgical Flaps
1
2009
110
0.290
 Why?
Recurrent Laryngeal Nerve
1
2007
12
0.290
 Why?
Laryngeal Nerves
1
2007
15
0.290
 Why?
Melanoma
2
2022
278
0.280
 Why?
Factor VII
1
2007
3
0.280
 Why?
Erythrocytes
2
2024
82
0.270
 Why?
Intracranial Arteriovenous Malformations
1
2007
30
0.270
 Why?
Dilatation
2
2017
26
0.260
 Why?
Malaria
2
2024
37
0.240
 Why?
Adolescent
11
2024
6453
0.240
 Why?
Gene Silencing
4
2009
114
0.230
 Why?
Disease Models, Animal
3
2016
1431
0.230
 Why?
Cell Proliferation
4
2016
980
0.210
 Why?
Melanoma, Experimental
2
2016
40
0.210
 Why?
Retrospective Studies
10
2015
6274
0.210
 Why?
Immunohistochemistry
8
2014
955
0.200
 Why?
Treatment Outcome
7
2018
5265
0.200
 Why?
Xerostomia
1
2002
2
0.200
 Why?
Promoter Regions, Genetic
7
2015
455
0.200
 Why?
Muscarinic Agonists
1
2002
11
0.200
 Why?
Sjogren's Syndrome
1
2002
9
0.200
 Why?
Endoscopy
2
2015
117
0.190
 Why?
Thiophenes
1
2002
36
0.190
 Why?
Plasmodium yoelii
1
2022
14
0.190
 Why?
Nitric Oxide Synthase Type III
2
2013
77
0.190
 Why?
Quinuclidines
1
2002
40
0.190
 Why?
Transcription Factors
2
2015
561
0.180
 Why?
Veins
3
2010
73
0.180
 Why?
Embolization, Therapeutic
3
2011
87
0.180
 Why?
Azepines
3
2016
19
0.180
 Why?
Triazoles
3
2016
113
0.170
 Why?
Child
10
2012
6931
0.160
 Why?
Child, Preschool
8
2012
3953
0.160
 Why?
Neoplasm Invasiveness
3
2010
269
0.160
 Why?
Mast Cells
1
2018
55
0.150
 Why?
Mice
10
2022
5659
0.150
 Why?
Ki-67 Antigen
3
2013
55
0.140
 Why?
Combined Modality Therapy
4
2018
640
0.140
 Why?
Cricoid Cartilage
1
2017
11
0.140
 Why?
Estradiol
1
2018
221
0.140
 Why?
Trachea
1
2017
53
0.140
 Why?
Mice, Nude
5
2016
247
0.140
 Why?
Biopsy
3
2015
588
0.130
 Why?
Follow-Up Studies
3
2011
2231
0.130
 Why?
Infant
7
2018
3648
0.130
 Why?
Lasers, Semiconductor
2
2022
10
0.130
 Why?
Embolism
1
2016
20
0.130
 Why?
Neoplasm Staging
2
2010
738
0.130
 Why?
Benzoxazoles
1
2016
11
0.130
 Why?
Matrix Metalloproteinase 2
1
2016
59
0.130
 Why?
Qualitative Research
1
2018
351
0.120
 Why?
Matrix Metalloproteinase 9
1
2016
88
0.120
 Why?
Tracheotomy
1
2015
14
0.120
 Why?
TOR Serine-Threonine Kinases
1
2016
76
0.120
 Why?
Tracheal Stenosis
1
2015
12
0.120
 Why?
Laryngostenosis
1
2015
11
0.120
 Why?
Aged, 80 and over
6
2015
3233
0.120
 Why?
Proto-Oncogene Proteins c-myb
1
2015
8
0.120
 Why?
Larynx
2
2017
30
0.120
 Why?
Pyrimidines
1
2016
187
0.110
 Why?
Disease Progression
3
2014
825
0.110
 Why?
Proto-Oncogene Proteins c-myc
1
2014
50
0.110
 Why?
Fluorouracil
2
2004
59
0.110
 Why?
Gene Expression Regulation, Neoplastic
3
2015
831
0.110
 Why?
DNA Methylation
5
2009
548
0.110
 Why?
Carcinoma
2
2012
137
0.110
 Why?
Breast Neoplasms
2
2015
1198
0.110
 Why?
Plasmodium falciparum
2
2024
18
0.110
 Why?
Apoptosis
2
2016
1092
0.110
 Why?
Animals
10
2022
13063
0.110
 Why?
Mastication
1
2012
5
0.100
 Why?
Trismus
1
2012
3
0.100
 Why?
DNA, Neoplasm
2
2011
144
0.100
 Why?
Cisplatin
2
2004
283
0.100
 Why?
Adaptor Proteins, Signal Transducing
3
2009
200
0.100
 Why?
Radiotherapy, Adjuvant
1
2012
63
0.100
 Why?
Recurrence
2
2011
657
0.100
 Why?
Receptors, Cell Surface
1
2013
117
0.100
 Why?
Lymphangioma, Cystic
1
2011
10
0.100
 Why?
Cross-Sectional Studies
3
2024
1601
0.100
 Why?
Chemoradiotherapy
1
2012
42
0.090
 Why?
Endothelium, Lymphatic
1
2011
12
0.090
 Why?
Syndrome
1
2012
236
0.090
 Why?
Antigens, CD
1
2013
221
0.090
 Why?
Epigenesis, Genetic
1
2015
371
0.090
 Why?
Administration, Topical
1
2011
67
0.090
 Why?
Propranolol
1
2012
79
0.090
 Why?
Lymphatic Abnormalities
1
2011
22
0.090
 Why?
Immunoenzyme Techniques
4
2016
140
0.090
 Why?
Enteral Nutrition
1
2012
149
0.090
 Why?
Microtubule-Associated Proteins
1
2011
66
0.090
 Why?
Deglutition Disorders
1
2012
77
0.090
 Why?
Homeodomain Proteins
1
2011
79
0.090
 Why?
Brain Neoplasms
1
2014
281
0.090
 Why?
Diagnosis, Differential
2
2011
1029
0.090
 Why?
Risk Assessment
1
2015
1268
0.090
 Why?
Tumor Suppressor Proteins
1
2011
127
0.090
 Why?
Weight Gain
1
2012
235
0.090
 Why?
Epigenomics
1
2011
65
0.090
 Why?
Xenograft Model Antitumor Assays
3
2016
210
0.090
 Why?
Neoplasm Proteins
2
2003
320
0.080
 Why?
Lip Neoplasms
1
2010
3
0.080
 Why?
Diagnostic Imaging
1
2011
182
0.080
 Why?
Neoplastic Stem Cells
1
2011
97
0.080
 Why?
Neoplasm Recurrence, Local
2
2019
622
0.080
 Why?
Survival Rate
3
2011
906
0.080
 Why?
Hospitals, Teaching
1
2010
52
0.080
 Why?
Lasers, Solid-State
1
2010
32
0.080
 Why?
Neoadjuvant Therapy
1
2011
119
0.080
 Why?
Microsatellite Instability
1
2009
19
0.080
 Why?
Young Adult
3
2024
4075
0.080
 Why?
Medical Records
1
2010
85
0.080
 Why?
Melanins
1
2009
26
0.080
 Why?
Mouth
1
2010
32
0.080
 Why?
Vascular Surgical Procedures
1
2011
165
0.080
 Why?
Multiple Endocrine Neoplasia Type 2a
1
2009
5
0.080
 Why?
Carcinoma, Medullary
1
2009
12
0.080
 Why?
Pilot Projects
1
2011
694
0.080
 Why?
Proto-Oncogene Proteins c-ret
1
2009
32
0.080
 Why?
Immunotherapy
1
2011
234
0.080
 Why?
Receptors, Estrogen
1
2009
132
0.080
 Why?
Receptors, Vascular Endothelial Growth Factor
1
2008
22
0.080
 Why?
Muscle, Smooth, Vascular
1
2009
130
0.080
 Why?
Port-Wine Stain
1
2008
14
0.080
 Why?
Blotting, Western
3
2016
575
0.070
 Why?
Dose-Response Relationship, Drug
1
2011
1369
0.070
 Why?
Early Detection of Cancer
2
2022
162
0.070
 Why?
Vascular Endothelial Growth Factor A
1
2008
180
0.070
 Why?
Cytokines
1
2011
602
0.070
 Why?
Thyroid Neoplasms
1
2009
109
0.070
 Why?
Tumor Cells, Cultured
3
2016
453
0.070
 Why?
Factor VIIa
1
2007
9
0.070
 Why?
Jaw Diseases
1
2007
6
0.070
 Why?
Practice Guidelines as Topic
1
2010
473
0.070
 Why?
Infant, Newborn
2
2011
2752
0.070
 Why?
Practice Management, Medical
1
2006
11
0.070
 Why?
Osteonecrosis
1
2007
34
0.070
 Why?
Postoperative Hemorrhage
1
2007
52
0.070
 Why?
Tongue
1
2007
40
0.070
 Why?
Bone Density Conservation Agents
1
2007
74
0.060
 Why?
Cell Line, Tumor
3
2015
1393
0.060
 Why?
Diphosphonates
1
2007
90
0.060
 Why?
Otolaryngology
1
2006
61
0.060
 Why?
Skin
1
2008
382
0.060
 Why?
Recombinant Proteins
1
2007
477
0.060
 Why?
Prospective Studies
1
2011
2378
0.060
 Why?
Mice, Inbred NOD
2
2016
89
0.060
 Why?
Mice, SCID
2
2016
171
0.060
 Why?
Cameroon
1
2024
4
0.060
 Why?
Hemeproteins
1
2024
8
0.060
 Why?
Parasitemia
1
2024
8
0.060
 Why?
Malaria, Falciparum
1
2024
14
0.060
 Why?
Neoplasm Metastasis
2
2015
230
0.060
 Why?
O(6)-Methylguanine-DNA Methyltransferase
1
2004
9
0.060
 Why?
DNA Repair Enzymes
1
2004
42
0.060
 Why?
Ataxia Telangiectasia
1
2004
6
0.060
 Why?
ROC Curve
1
2024
223
0.060
 Why?
Statistics, Nonparametric
1
2004
189
0.060
 Why?
Polymerase Chain Reaction
4
2009
447
0.050
 Why?
Genes, p16
1
2003
8
0.050
 Why?
Lymph Node Excision
1
2004
131
0.050
 Why?
Radiotherapy
1
2004
125
0.050
 Why?
Proteoglycans
1
2003
81
0.050
 Why?
Magnetic Resonance Angiography
2
2018
71
0.050
 Why?
Magnetic Resonance Imaging
2
2007
1546
0.050
 Why?
Antigens, Nuclear
2
2013
23
0.050
 Why?
Transplantation, Heterologous
2
2013
73
0.050
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2016
568
0.050
 Why?
Sensitivity and Specificity
1
2024
855
0.050
 Why?
Longitudinal Studies
1
2024
732
0.050
 Why?
Membrane Glycoproteins
1
2003
246
0.050
 Why?
Double-Blind Method
1
2002
710
0.040
 Why?
Survival Analysis
3
2009
658
0.040
 Why?
Tryptases
1
2018
4
0.040
 Why?
Arkansas
1
2004
1974
0.040
 Why?
Estrogen Receptor beta
1
2018
56
0.040
 Why?
Estrogen Receptor alpha
1
2018
90
0.040
 Why?
Protein Transport
1
2018
183
0.040
 Why?
Ultrasonography, Doppler
1
2018
41
0.040
 Why?
Biopsy, Fine-Needle
2
2009
108
0.040
 Why?
Cadaver
1
2017
95
0.030
 Why?
Pressure
1
2017
104
0.030
 Why?
Serum
1
2016
32
0.030
 Why?
Risk Factors
3
2015
3712
0.030
 Why?
Molecular Imaging
1
2016
54
0.030
 Why?
Drug Synergism
1
2016
149
0.030
 Why?
Jumonji Domain-Containing Histone Demethylases
1
2015
17
0.030
 Why?
Real-Time Polymerase Chain Reaction
1
2016
179
0.030
 Why?
Enhancer Elements, Genetic
1
2015
57
0.030
 Why?
Acetylation
1
2015
94
0.030
 Why?
Keratin-20
1
2014
7
0.030
 Why?
Mammography
1
2015
100
0.030
 Why?
G1 Phase Cell Cycle Checkpoints
1
2014
16
0.030
 Why?
Drug Therapy, Combination
1
2016
387
0.030
 Why?
Prognosis
3
2004
1974
0.030
 Why?
Chromatin
1
2015
133
0.030
 Why?
Cell Cycle Proteins
1
2015
163
0.030
 Why?
Gene Expression Regulation
1
2018
948
0.030
 Why?
HEK293 Cells
1
2014
209
0.030
 Why?
Vascular Endothelial Growth Factor Receptor-2
1
2013
30
0.030
 Why?
Comorbidity
1
2015
621
0.030
 Why?
Protein Binding
1
2015
648
0.030
 Why?
Down-Regulation
1
2014
338
0.030
 Why?
Actins
1
2013
112
0.020
 Why?
RNA, Messenger
1
2016
1085
0.020
 Why?
Base Sequence
2
2004
622
0.020
 Why?
Lymphocele
1
2011
7
0.020
 Why?
Tissue Survival
1
2011
10
0.020
 Why?
Cell Line
1
2014
997
0.020
 Why?
Predictive Value of Tests
1
2014
924
0.020
 Why?
Antibodies, Monoclonal, Murine-Derived
1
2011
44
0.020
 Why?
Tissue Culture Techniques
1
2011
37
0.020
 Why?
Neoplasms, Squamous Cell
1
2011
7
0.020
 Why?
Gluconates
1
2011
1
0.020
 Why?
Gene Expression Profiling
1
2016
1020
0.020
 Why?
Graft Survival
1
2011
160
0.020
 Why?
Indomethacin
1
2011
35
0.020
 Why?
Injections, Subcutaneous
1
2011
52
0.020
 Why?
Interleukin-2
1
2011
70
0.020
 Why?
Carrier Proteins
2
2003
297
0.020
 Why?
Time Factors
2
2007
2933
0.020
 Why?
Interleukin-1beta
1
2011
72
0.020
 Why?
Cyclophosphamide
1
2011
168
0.020
 Why?
Interferon-gamma
1
2011
175
0.020
 Why?
Drug Administration Schedule
1
2011
373
0.020
 Why?
Disease-Free Survival
1
2011
439
0.020
 Why?
Glottis
1
2010
34
0.020
 Why?
Endothelial Cells
1
2011
256
0.020
 Why?
Sclerotherapy
1
2010
46
0.020
 Why?
Calcitonin
1
2009
30
0.020
 Why?
Tumor Necrosis Factor-alpha
1
2011
386
0.020
 Why?
Thyroidectomy
1
2009
60
0.020
 Why?
Paraffin Embedding
1
2008
51
0.020
 Why?
Mice, Transgenic
1
2009
537
0.020
 Why?
Signal Transduction
1
2014
1608
0.020
 Why?
Curettage
1
2007
12
0.020
 Why?
Dental Care
1
2007
12
0.020
 Why?
Mouth Floor
1
2007
5
0.020
 Why?
Polyvinyl Alcohol
1
2007
9
0.020
 Why?
Hyperbaric Oxygenation
1
2007
14
0.020
 Why?
Current Procedural Terminology
1
2006
7
0.020
 Why?
Collateral Circulation
1
2007
39
0.020
 Why?
Pharyngeal Diseases
1
2007
12
0.020
 Why?
Insurance, Health, Reimbursement
1
2006
24
0.020
 Why?
Cutaneous Fistula
1
2007
14
0.020
 Why?
Neck Dissection
1
2007
30
0.020
 Why?
Angiography
1
2007
128
0.020
 Why?
Fistula
1
2007
26
0.020
 Why?
Office Visits
1
2006
53
0.020
 Why?
Genetic Predisposition to Disease
1
2009
507
0.020
 Why?
Salvage Therapy
1
2007
137
0.020
 Why?
Adrenal Cortex Hormones
1
2007
102
0.020
 Why?
Imidazoles
1
2007
125
0.020
 Why?
Preoperative Care
1
2007
170
0.020
 Why?
Ultrasonography
1
2006
434
0.010
 Why?
United States
1
2015
5005
0.010
 Why?
Guanine
1
2004
40
0.010
 Why?
DNA Adducts
1
2004
79
0.010
 Why?
Methylation
1
2004
117
0.010
 Why?
Syndecans
1
2003
35
0.010
 Why?
Syndecan-1
1
2003
73
0.010
 Why?
Base Pair Mismatch
1
2003
21
0.010
 Why?
Cell Count
1
2003
150
0.010
 Why?
Antineoplastic Agents
1
2011
1165
0.010
 Why?
DNA Repair
1
2003
187
0.010
 Why?
Alcohol Drinking
1
2003
228
0.010
 Why?
Molecular Sequence Data
1
2003
760
0.010
 Why?
Anti-Bacterial Agents
1
2007
751
0.010
 Why?
Smoking
1
2003
506
0.010
 Why?
Multiple Myeloma
1
2007
2990
0.010
 Why?
Suen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (317) concept(s)
_
Co-Authors Expand Description
See all (21) people
_
Similar People Expand Description
See all (33) people
_
Same Department Expand Description
Search Department